SMTL ID : 7vrm.1

crystal structure of BRD2-BD2 in complex with purine derivative

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.10 Å

Oligo State

homo-dimer

Ligands

4 x TEP: THEOPHYLLINE(Non-covalent)

TEP.1: 8 residues within 4Å: Chain A: P.31, V.36, L.41, L.43, C.85, N.89, H.93, V.95 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.89, A:N.89 TEP.2: 1 residues within 4Å: Chain A: W.30 2 PLIP interactions: 2 interactions with chain A pi-Stacking: A:W.30, A:W.30 TEP.3: 8 residues within 4Å: Chain B: P.31, V.36, L.41, L.43, C.85, N.89, H.93, V.95 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:N.89, B:N.89 TEP.4: 1 residues within 4Å: Chain B: W.30 2 PLIP interactions: 2 interactions with chain B pi-Stacking: B:W.30, B:W.30

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Arole, A.H. et al., Structural and biochemical insights into purine-based drug molecules in hBRD2 delineate a unique binding mode opening new vistas in the design of inhibitors of the BET family. Acta Crystallogr D Struct Biol (2023)

Release Date

2023-02-01

Peptides

Bromodomain-containing protein 2: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

Bromodomain-containing protein 2

Related Entries With Identical Sequence